ALXN

Alexion Pharmaceuticals, Inc. News Headlines

$149.8
*  
0.75
 negative 
0.5%
Get ALXN Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALXN Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Milestone Payment for Ligand Pharma - Analyst Blog
3/18/2014 5:30:01 PM - Zacks.com

Repros Provides Proellex Update - Analyst Blog
3/18/2014 5:10:01 PM - Zacks.com

Pipeline Update from BioDelivery Sciences - Analyst Blog
3/18/2014 5:00:01 PM - Zacks.com

Intercept Sees Weakness in Earnings Result - Analyst Blog
3/18/2014 4:45:01 PM - Zacks.com

Amgen Scores Again with PCSK9 Inhibitor - Analyst Blog
3/18/2014 3:50:01 PM - Zacks.com

Biogen to be added to S&P100 - Analyst Blog
3/18/2014 1:50:01 PM - Zacks.com

Bristol-Myers, Five Prime Join Forces, Shares up - Analyst Blog
3/18/2014 12:00:01 PM - Zacks.com

Horizon Pharma (HZNP) Jumps: Stock Rises 5.6% - Tale of the Tape
3/18/2014 9:21:01 AM - Zacks.com

Narrower-Than-Expected Loss at Relypsa - Analyst Blog
3/18/2014 9:20:01 AM - Zacks.com

Five Prime Therapeutics (FPRX) Surges: Stock Moves 22.6% Higher - Tale of the Tape
3/18/2014 9:18:01 AM - Zacks.com

Update on Bayer's Adempas - Analyst Blog
3/17/2014 2:23:01 PM - Zacks.com

Update on Glaxo's Pipeline - Analyst Blog
3/17/2014 1:53:01 PM - Zacks.com

Raptor Pharma Posts Wider-Than-Expected Q4 Loss - Analyst Blog
3/14/2014 11:40:01 AM - Zacks.com

Progenics Q4 Loss Narrower Than Expected - Analyst Blog
3/14/2014 11:40:01 AM - Zacks.com

Revenues Decline at Discovery Labs in Q4, Shares Down - Analyst Blog
3/14/2014 11:30:01 AM - Zacks.com

Narrower-than-Expected Q4 Loss at Repros - Analyst Blog
3/14/2014 9:50:01 AM - Zacks.com

Vanda Pharmaceuticals (VNDA) Soars: Stock Adds 9.6% in Session - Tale of the Tape
3/14/2014 9:21:01 AM - Zacks.com

AVEO Q4 Loss Narrower than Expected - Analyst Blog
3/14/2014 9:10:01 AM - Zacks.com

Insmed (INSM) Looks Good: Stock Adds 5.9% in Session - Tale of the Tape
3/14/2014 9:04:01 AM - Zacks.com

Bright Outlook at Bayer - Analyst Blog
3/13/2014 4:45:01 PM - Zacks.com

Geron Plunges on FDA Clinical Hold - Analyst Blog
3/13/2014 1:10:01 PM - Zacks.com

Fate Therapeutics' Prohema in Phase II Study - Analyst Blog
3/13/2014 11:50:01 AM - Zacks.com

AstraZeneca to Sell Cheshire Research Site - Analyst Blog
3/13/2014 11:30:01 AM - Zacks.com

Acura Pharmaceuticals, Inc. (ACUR) in Focus: Stock Moves 7.7% Higher - Tale of the Tape
3/13/2014 8:44:01 AM - Zacks.com

Bayer/Amgen's Nexavar Fails in Late-Stage Study - Analyst Blog
3/12/2014 6:45:01 PM - Zacks.com